SYLVIA CROWHURST: Open Payments
NPI 1821871120 · GREENVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,948 in 100 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $1,858 · 2025 $1,948
Food & beverage: $1,948
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $546 |
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $319 |
| Janssen Biotech, Inc. | 9 | $172 |
| Aimmune Therapeutics, Inc. | 7 | $166 |
| PFIZER INC. | 14 | $156 |
| GENZYME CORPORATION | 6 | $156 |
| Regeneron Healthcare Solutions, Inc. | 5 | $144 |
| Lilly USA, LLC | 3 | $63 |
| Novo Nordisk Inc | 3 | $59 |
| Celltrion USA Inc. | 1 | $40 |
Products named: RINVOQ, DUPIXENT, ENTYVIO, TREMFYA, ZENPEP, SKYRIZI, XELJANZ, Linzess.
Industry payments across NC — which companies pay providers there.
